The Global Irritable Bowel Syndrome (IBS) Diagnostics Market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5% from 2022 to 2028. Irritable Bowel Syndrome (IBS) is defined as a gastrointestinal disorder that causes gastrointestinal discomfort along with diarrhea and […]
